Retrieve available abstracts of 126 articles: HTML format
Single Articles
June 2025
SUI YV, Bertisch H, Goff DC, Samsonov A, et al Quantitative magnetization transfer and g-ratio imaging of white matter myelin in
early psychotic spectrum disorders.
Mol Psychiatry. 2025;30:2739-2747. PubMedAbstract available
May 2025
VILLARIN JM, Kellendonk C An ace in the hole? Opportunities and limits of using mice to understand
schizophrenia neurobiology.
Mol Psychiatry. 2025 May 22. doi: 10.1038/s41380-025-03060. PubMedAbstract available
BYUN AJS, Lane E, Langholm C, Flathers M, et al Towards clinical subtypes in schizophrenia: integrating cognitive, functional,
and digital phenotyping assessments.
Mol Psychiatry. 2025 May 20. doi: 10.1038/s41380-025-03054. PubMedAbstract available
SAINT-GEORGES Z, MacDonald J, Al-Khalili R, Hamati R, et al Cholinergic system in schizophrenia: A systematic review and meta-analysis.
Mol Psychiatry. 2025 May 20. doi: 10.1038/s41380-025-03023. PubMedAbstract available
HUA L, Zeng X, Zhang K, Zhao Z, et al Reduced glymphatic clearance in early psychosis.
Mol Psychiatry. 2025 May 19. doi: 10.1038/s41380-025-03058. PubMedAbstract available
BANERJEE A, Wang HY, Borgmann-Winter KE, MacDonald ML, et al Editorial Expression of Concern: Src kinase as a mediator of convergent molecular
abnormalities leading to NMDAR hypoactivity in schizophrenia.
Mol Psychiatry. 2025 May 13. doi: 10.1038/s41380-025-03050. PubMed
FARHANGDOOST N, Liao C, Liu Y, Rochefort D, et al Transcriptomic and epigenomic consequences of heterozygous loss-of-function
mutations in AKAP11, a shared risk gene for bipolar disorder and schizophrenia.
Mol Psychiatry. 2025 May 2. doi: 10.1038/s41380-025-03040. PubMedAbstract available
HATANO M, Nakajima W, Tani H, Uchida H, et al Characterization of patients with major psychiatric disorders with AMPA receptor
positron emission tomography.
Mol Psychiatry. 2025;30:1780-1790. PubMedAbstract available
April 2025
WANG HY, MacDonald ML, Borgmann-Winter KE, Banerjee A, et al Retraction Note: mGluR5 hypofunction is integral to glutamatergic dysregulation
in schizophrenia.
Mol Psychiatry. 2025 Apr 17. doi: 10.1038/s41380-025-02986. PubMed
HATZIPANAYIOTI A, Walther S, Gangl N, Conring F, et al Aberrant personal space is associated with paranoia, altered stress regulation,
and unfavourable outcomes at 6 months' follow-up in schizophrenia.
Mol Psychiatry. 2025 Apr 9. doi: 10.1038/s41380-025-02999. PubMedAbstract available
NUCIFORA LG, Ishizuka K, El Demerdash N, Lee BJ, et al Protein aggregation identified in olfactory neuronal cells is associated with
cognitive impairments in a subset of living schizophrenia patients.
Mol Psychiatry. 2025 Apr 3. doi: 10.1038/s41380-025-02956. PubMedAbstract available
XIE Y, Fu J, Liu L, Wang X, et al Genetic and neural mechanisms shared by schizophrenia and depression.
Mol Psychiatry. 2025 Apr 3. doi: 10.1038/s41380-025-02975. PubMedAbstract available
YAO S, Kendrick KM How does oxytocin modulate human behavior?
Mol Psychiatry. 2025;30:1639-1651. PubMedAbstract available
MIURA K, Yoshida M, Morita K, Fujimoto M, et al Gaze behaviors during free viewing revealed differences in visual salience
processing across four major psychiatric disorders: a mega-analysis study of 1012
individuals.
Mol Psychiatry. 2025;30:1594-1600. PubMedAbstract available
ITAHASHI T, Yamashita A, Takahara Y, Yahata N, et al Generalizable and transportable resting-state neural signatures characterized by
functional networks, neurotransmitters, and clinical symptoms in autism.
Mol Psychiatry. 2025;30:1466-1478. PubMedAbstract available
March 2025
GIACOMEL A, Martins D, Nordio G, Easmin R, et al Correction: Investigating dopaminergic abnormalities in schizophrenia and
first-episode psychosis with normative modelling and multisite molecular
neuroimaging.
Mol Psychiatry. 2025 Mar 31. doi: 10.1038/s41380-025-02987. PubMed
RABALLO A, Poletti M, Preti A Increasing conceptual clarity and confounders identification: a pragmatic way to
enhance prognostic precision in ENIGMA clinical high risk for psychosis (CHR-P).
Mol Psychiatry. 2025 Mar 17. doi: 10.1038/s41380-025-02948. PubMed
FENG YA, Chen WJ, Lin MC, Hsu JS, et al Paternal age, de novo mutation, and age at onset among co-affected schizophrenia
sib-pairs: whole-genome sequencing in multiplex families.
Mol Psychiatry. 2025 Mar 5. doi: 10.1038/s41380-025-02942. PubMedAbstract available
ZHAO Q, Wei X, Yu W, Li X, et al Morphological alterations of the thymus gland in individuals with schizophrenia.
Mol Psychiatry. 2025 Mar 4. doi: 10.1038/s41380-025-02946. PubMedAbstract available
ARBABI K, Newton DF, Oh H, Davie MC, et al Transcriptomic pathology of neocortical microcircuit cell types across
psychiatric disorders.
Mol Psychiatry. 2025;30:1057-1068. PubMedAbstract available
KENDLER KS, Ohlsson H, Sundquist J, Sundquist K, et al The number of episodes of major psychiatric and substance use disorders as an
index of genetic risk and genetic heterogeneity.
Mol Psychiatry. 2025;30:968-975. PubMedAbstract available
February 2025
GIACOMEL A, Martins D, Nordio G, Easmin R, et al Investigating dopaminergic abnormalities in schizophrenia and first-episode
psychosis with normative modelling and multisite molecular neuroimaging.
Mol Psychiatry. 2025 Feb 28. doi: 10.1038/s41380-025-02938. PubMedAbstract available
KEIHANI A, Donati FL, Janssen SA, Huston CA, et al Multimodal evidence of mediodorsal thalamus-prefrontal circuit dysfunctions in
clinical high-risk for psychosis: findings from a combined 7T fMRI, MRSI and
sleep Hd-EEG study.
Mol Psychiatry. 2025 Feb 15. doi: 10.1038/s41380-025-02924. PubMedAbstract available
MINICHINO A, Davies C, Karpenko O, Christodoulou N, et al Preventing psychosis in people at clinical high risk: an updated meta-analysis by
the World Psychiatric Association Preventive Psychiatry section.
Mol Psychiatry. 2025 Feb 14. doi: 10.1038/s41380-025-02902. PubMedAbstract available
DI RE J, Marini M, Hussain SI, Singh AK, et al betaIV spectrin abundancy, cellular distribution and sensitivity to AKT/GSK3
regulation in schizophrenia.
Mol Psychiatry. 2025 Feb 7. doi: 10.1038/s41380-025-02917. PubMedAbstract available
VINKE LN, Avanaki M, Jeffrey C, Harikumar A, et al Neural correlates of personal space regulation in psychosis: role of the inferior
parietal cortex.
Mol Psychiatry. 2025 Feb 3. doi: 10.1038/s41380-025-02906. PubMedAbstract available
January 2025
CHESTNYKH D, Muhle C, Schumacher F, Kalinichenko LS, et al Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment
strategy for schizophrenia.
Mol Psychiatry. 2025 Jan 17. doi: 10.1038/s41380-025-02893. PubMedAbstract available
MARQUES D, Vaziri N, Greenway SC, Bousman C, et al DNA methylation and histone modifications associated with antipsychotic
treatment: a systematic review.
Mol Psychiatry. 2025;30:296-309. PubMedAbstract available
CIULKINYTE A, Mountford HS, Fontanillas P, Bates TC, et al Genetic neurodevelopmental clustering and dyslexia.
Mol Psychiatry. 2025;30:140-150. PubMedAbstract available
LI X, Xue C, Zhu Z, Yu X, et al Application of GWAS summary data and drug-induced gene expression profiles of
neural progenitor cells in psychiatric drug prioritization analysis.
Mol Psychiatry. 2025;30:111-121. PubMedAbstract available
December 2024
EISENBERG DP, Blackman RK, Tietcheu MG, Kohn PD, et al Genetic risk for treatment resistant schizophrenia and corresponding variation in
dopamine synthesis capacity and D(2/3) receptor availability in healthy
individuals.
Mol Psychiatry. 2024 Dec 27. doi: 10.1038/s41380-024-02873. PubMedAbstract available
XIA C, Alliey-Rodriguez N, Tamminga CA, Keshavan MS, et al Genetic analysis of psychosis Biotypes: shared Ancestry-adjusted polygenic risk
and unique genomic associations.
Mol Psychiatry. 2024 Dec 21. doi: 10.1038/s41380-024-02876. PubMedAbstract available
SOLMI M, Fornaro M, Caiolo S, Lussignoli M, et al Efficacy and acceptability of pharmacological interventions for tardive
dyskinesia in people with schizophrenia or mood disorders: a systematic review
and network meta-analysis.
Mol Psychiatry. 2024 Dec 18. doi: 10.1038/s41380-024-02733. PubMedAbstract available
COHEN LS, Arakelian M, Church TR, Dunk MM, et al The phenomenology of postpartum psychosis: preliminary findings from the
Massachusetts General Hospital Postpartum Psychosis Project.
Mol Psychiatry. 2024 Dec 6. doi: 10.1038/s41380-024-02856. PubMedAbstract available
BERNSTEIN HG, Nussbaumer M, Vasilevska V, Dobrowolny H, et al Glial cell deficits are a key feature of schizophrenia: implications for neuronal
circuit maintenance and histological differentiation from classical
neurodegeneration.
Mol Psychiatry. 2024 Dec 5. doi: 10.1038/s41380-024-02861. PubMedAbstract available
SCHALBROECK R, van Hooijdonk CFM, Bos DPA, Booij J, et al Chronic social stressors and striatal dopamine functioning in humans: A
systematic review of SPECT and PET studies.
Mol Psychiatry. 2024;29:3841-3856. PubMedAbstract available
November 2024
SABE M, Sulstarova A, Glangetas A, De Pieri M, et al Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews,
a systematic review, and meta-analysis of human studies.
Mol Psychiatry. 2024 Nov 27. doi: 10.1038/s41380-024-02800. PubMedAbstract available
NELSON EA, Kraguljac NV, Bashir A, Cofield SS, et al A longitudinal study of hippocampal subfield volumes and hippocampal glutamate
levels in antipsychotic-naive first episode psychosis patients.
Mol Psychiatry. 2024 Nov 23. doi: 10.1038/s41380-024-02812. PubMedAbstract available
WEIDENAUER A, Dajic I, Praschak-Rieder N, Willeit M, et al The dopaminergic basis of negative symptoms in schizophrenia: an addendum.
Mol Psychiatry. 2024 Nov 20. doi: 10.1038/s41380-024-02828. PubMed
CHEN L, Huai C, Song C, Wu S, et al Refining antipsychotic treatment strategies in schizophrenia: discovery of
genetic biomarkers for enhanced drug response prediction.
Mol Psychiatry. 2024 Nov 19. doi: 10.1038/s41380-024-02841. PubMedAbstract available
WALKER A, Karlsson R, Szatkiewicz JP, Thornton LM, et al Genome-wide copy number variation association study in anorexia nervosa.
Mol Psychiatry. 2024 Nov 12. doi: 10.1038/s41380-024-02811. PubMedAbstract available
NISHA AJI K, Lalang N, Ramos-Jimenez C, Rahimian R, et al Evidence of altered monoamine oxidase B, an astroglia marker, in early psychosis
and high-risk state.
Mol Psychiatry. 2024 Nov 7. doi: 10.1038/s41380-024-02816. PubMedAbstract available
SOCRATES AJ, Mullins N, Gur RC, Gur RE, et al Polygenic risk of social isolation behavior and its influence on psychopathology
and personality.
Mol Psychiatry. 2024;29:3599-3606. PubMedAbstract available
LUO J, Li L, Niu M, Kong D, et al Genetic regulation of human brain proteome reveals proteins implicated in
psychiatric disorders.
Mol Psychiatry. 2024;29:3330-3343. PubMedAbstract available
October 2024
LEE H, Lee JH, Lee S, Lim JS, et al Comorbid health outcomes in patients with schizophrenia: an umbrella review of
systematic reviews and meta-analyses.
Mol Psychiatry. 2024 Oct 18. doi: 10.1038/s41380-024-02792. PubMedAbstract available
DEVINE EA, Imami AS, Eby H, Sahay S, et al Neuronal alterations in AKT isotype expression in schizophrenia.
Mol Psychiatry. 2024 Oct 18. doi: 10.1038/s41380-024-02770. PubMedAbstract available
SCOTT DS, Subramanian M, Yamamoto J, Tamminga CA, et al Schizophrenia pathology reverse-translated into mouse shows hippocampal
hyperactivity, psychosis behaviors and hyper-synchronous events.
Mol Psychiatry. 2024 Oct 16. doi: 10.1038/s41380-024-02781. PubMedAbstract available
DEMPSTER EL, Wong CCY, Burrage J, Hannon E, et al Methylomic signature of current cannabis use in two first-episode psychosis
cohorts.
Mol Psychiatry. 2024 Oct 16. doi: 10.1038/s41380-024-02689. PubMedAbstract available
KEANE BP, Abrham YT, Cole MW, Johnson BA, et al Functional dysconnectivity of visual and somatomotor networks yields a simple and
robust biomarker for psychosis.
Mol Psychiatry. 2024 Oct 4. doi: 10.1038/s41380-024-02767. PubMedAbstract available
LIUFU C, Luo L, Pang T, Zheng H, et al Integration of multi-omics summary data reveals the role of N6-methyladenosine in
neuropsychiatric disorders.
Mol Psychiatry. 2024;29:3141-3150. PubMedAbstract available
September 2024
CHOE E, Kim M, Choi S, Oh H, et al MRI textural plasticity in limbic gray matter associated with clinical response
to electroconvulsive therapy for psychosis.
Mol Psychiatry. 2024 Sep 26. doi: 10.1038/s41380-024-02755. PubMedAbstract available
SAPIENZA J, Martini F, Comai S, Cavallaro R, et al Psychedelics and schizophrenia: a double-edged sword.
Mol Psychiatry. 2024 Sep 18. doi: 10.1038/s41380-024-02743. PubMedAbstract available
KILTSCHEWSKIJ DJ, Reay WR, Cairns MJ Schizophrenia is associated with altered DNA methylation variance.
Mol Psychiatry. 2024 Sep 13. doi: 10.1038/s41380-024-02749. PubMedAbstract available
GARCIA-SAN-MARTIN N, Bethlehem RAI, Mihalik A, Seidlitz J, et al Molecular and micro-architectural mapping of gray matter alterations in
psychosis.
Mol Psychiatry. 2024 Sep 12. doi: 10.1038/s41380-024-02724. PubMedAbstract available
NANI JV, Muotri AR, Hayashi MAF Peering into the mind: unraveling schizophrenia's secrets using models.
Mol Psychiatry. 2024 Sep 8. doi: 10.1038/s41380-024-02728. PubMedAbstract available
ROMANOVSKY E, Choudhary A, Peles D, Abu-Akel A, et al Uncovering convergence and divergence between autism and schizophrenia using
genomic tools and patients' neurons.
Mol Psychiatry. 2024 Sep 5. doi: 10.1038/s41380-024-02740. PubMedAbstract available
PHADKE RA, Brack A, Fournier LA, Kruzich E, et al The schizophrenia risk gene C4 induces pathological synaptic loss by impairing
AMPAR trafficking.
Mol Psychiatry. 2024 Sep 3. doi: 10.1038/s41380-024-02701. PubMedAbstract available
CHAN JKN, Lee KCK, Correll CU, So YK, et al Adverse obstetric and neonatal outcomes associated with maternal
schizophrenia-spectrum disorders and prenatal antipsychotic use: a meta-analysis
of 37,214,330 pregnancy deliveries and propensity-score weighted population-based
cohort study assessing
Mol Psychiatry. 2024 Sep 2. doi: 10.1038/s41380-024-02723. PubMedAbstract available
CROUSE JJ, Park SH, Byrne EM, Mitchell BL, et al Patterns of stressful life events and polygenic scores for five mental disorders
and neuroticism among adults with depression.
Mol Psychiatry. 2024;29:2765-2773. PubMedAbstract available
GAITONDE SA, Avet C, de la Fuente Revenga M, Blondel-Tepaz E, et al Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT(2A)
receptor.
Mol Psychiatry. 2024;29:2753-2764. PubMedAbstract available
KAMPE A, Suvisaari J, Lahteenvuo M, Singh T, et al Genetic contribution to disease-course severity and progression in the
SUPER-Finland study, a cohort of 10,403 individuals with psychotic disorders.
Mol Psychiatry. 2024;29:2733-2741. PubMedAbstract available
GERACI F, Passiatore R, Penzel N, Laudani S, et al Sex dimorphism controls dysbindin-related cognitive dysfunctions in mice and
humans with the contribution of COMT.
Mol Psychiatry. 2024;29:2666-2677. PubMedAbstract available
August 2024
KAMBALI M, Li Y, Unichenko P, Feria Pliego JA, et al An increased copy number of glycine decarboxylase (GLDC) associated with
psychosis reduces extracellular glycine and impairs NMDA receptor function.
Mol Psychiatry. 2024 Aug 30. doi: 10.1038/s41380-024-02711. PubMedAbstract available
AYMERICH C, Salazar de Pablo G, Pacho M, Perez-Rodriguez V, et al All-cause mortality risk in long-acting injectable versus oral antipsychotics in
schizophrenia: a systematic review and meta-analysis.
Mol Psychiatry. 2024 Aug 22. doi: 10.1038/s41380-024-02694. PubMedAbstract available
LI Z, Mukherjee D, Duric B, Austin-Zimmerman I, et al Systematic review and meta-analysis on the effects of chronic peri-adolescent
cannabinoid exposure on schizophrenia-like behaviour in rodents.
Mol Psychiatry. 2024 Aug 2. doi: 10.1038/s41380-024-02668. PubMedAbstract available
ALLOTT K, Chopra S, Rogers J, Dauvermann MR, et al Advancing understanding of the mechanisms of antipsychotic-associated cognitive
impairment to minimise harm: a call to action.
Mol Psychiatry. 2024;29:2571-2574. PubMed
July 2024
FORNARO M, Caiazza C, Billeci M, Berk M, et al Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic
review and network meta-analysis "Nutra NMA SCZ".
Mol Psychiatry. 2024 Jul 18. doi: 10.1038/s41380-024-02645. PubMedAbstract available
ARANDA S, Jimenez E, Canales-Rodriguez EJ, Verdolini N, et al Processing speed mediates the relationship between DDR1 and psychosocial
functioning in euthymic patients with bipolar disorder presenting psychotic
symptoms.
Mol Psychiatry. 2024;29:2050-2058. PubMedAbstract available
June 2024
CAMPORESI S, Xin L, Golay P, Eap CB, et al Neurocognition and NMDAR co-agonists pathways in individuals with treatment
resistant first-episode psychosis: a 3-year follow-up longitudinal study.
Mol Psychiatry. 2024 Jun 7. doi: 10.1038/s41380-024-02631. PubMedAbstract available
MARTINO M, Magioncalda P A working model of neural activity and phenomenal experience in psychosis.
Mol Psychiatry. 2024 Jun 6. doi: 10.1038/s41380-024-02607. PubMedAbstract available
CHO KIK, Zhang F, Penzel N, Seitz-Holland J, et al Excessive interstitial free-water in cortical gray matter preceding accelerated
volume changes in individuals at clinical high risk for psychosis.
Mol Psychiatry. 2024 Jun 3. doi: 10.1038/s41380-024-02597. PubMedAbstract available
LIAO Y, Yu H, Zhang Y, Lu Z, et al Genome-wide association study implicates lipid pathway dysfunction in
antipsychotic-induced weight gain: multi-ancestry validation.
Mol Psychiatry. 2024;29:1857-1868. PubMedAbstract available
May 2024
STERN S, Zhang L, Wang M, Wright R, et al Monozygotic twins discordant for schizophrenia differ in maturation and synaptic
transmission.
Mol Psychiatry. 2024 May 4. doi: 10.1038/s41380-024-02561. PubMedAbstract available
HILL MD, Gill SS, Le-Niculescu H, MacKie O, et al Precision medicine for psychotic disorders: objective assessment, risk
prediction, and pharmacogenomics.
Mol Psychiatry. 2024;29:1528-1549. PubMedAbstract available
YANG K, Hasegawa Y, Bhattarai JP, Hua J, et al Inflammation-related pathology in the olfactory epithelium: its impact on the
olfactory system in psychotic disorders.
Mol Psychiatry. 2024;29:1453-1464. PubMedAbstract available
April 2024
SPATHOPOULOU A, Sauerwein GA, Marteau V, Podlesnic M, et al Integrative metabolomics-genomics analysis identifies key networks in a stem
cell-based model of schizophrenia.
Mol Psychiatry. 2024 Apr 29. doi: 10.1038/s41380-024-02568. PubMedAbstract available
SHARKEY RJ, Bacon C, Peterson Z, Rootes-Murdy K, et al Differences in the neural correlates of schizophrenia with positive and negative
formal thought disorder in patients with schizophrenia in the ENIGMA dataset.
Mol Psychiatry. 2024 Apr 26. doi: 10.1038/s41380-024-02563. PubMedAbstract available
SUPEKAR K, de Los Angeles C, Ryali S, Kushan L, et al Robust and replicable functional brain signatures of 22q11.2 deletion syndrome
and associated psychosis: a deep neural network-based multi-cohort study.
Mol Psychiatry. 2024 Apr 12. doi: 10.1038/s41380-024-02495. PubMedAbstract available
TOTZEK JF, Chakravarty MM, Joober R, Malla A, et al Longitudinal inference of multiscale markers in psychosis: from hippocampal
centrality to functional outcome.
Mol Psychiatry. 2024 Apr 11. doi: 10.1038/s41380-024-02549. PubMedAbstract available
OKADA N, Yahata N, Koshiyama D, Morita K, et al Longitudinal trajectories of anterior cingulate glutamate and subclinical
psychotic experiences in early adolescence: the impact of bullying victimization.
Mol Psychiatry. 2024;29:939-950. PubMedAbstract available
March 2024
CHEN S, Tan Y, Tian L Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?
Mol Psychiatry. 2024 Mar 26. doi: 10.1038/s41380-024-02539. PubMedAbstract available
KOSKUVI M, Porsti E, Hewitt T, Rasanen N, et al Genetic contribution to microglial activation in schizophrenia.
Mol Psychiatry. 2024 Mar 22. doi: 10.1038/s41380-024-02529. PubMedAbstract available
TESFAYE M, Spindola LM, Stavrum AK, Shadrin A, et al Sex effects on DNA methylation affect discovery in epigenome-wide association
study of schizophrenia.
Mol Psychiatry. 2024 Mar 19. doi: 10.1038/s41380-024-02513. PubMedAbstract available
FEOLA B, Beermann A, Manzanarez Felix K, Coleman M, et al Data-driven, connectome-wide analysis identifies psychosis-specific brain
correlates of fear and anxiety.
Mol Psychiatry. 2024 Mar 19. doi: 10.1038/s41380-024-02512. PubMedAbstract available
BIGDELI TB, Barr PB, Rajeevan N, Graham DP, et al Correlates of suicidal behaviors and genetic risk among United States veterans
with schizophrenia or bipolar I disorder.
Mol Psychiatry. 2024 Mar 15. doi: 10.1038/s41380-024-02472. PubMedAbstract available
WARREN TL, Tubbs JD, Lesh TA, Corona MB, et al Association of neurotransmitter pathway polygenic risk with specific symptom
profiles in psychosis.
Mol Psychiatry. 2024 Mar 15. doi: 10.1038/s41380-024-02457. PubMedAbstract available
February 2024
FOUNTOULAKIS KN, Tsapakis EM Neither serotonin disorder is at the core of depression nor dopamine at the core
of schizophrenia; still these are biologically based mental disorders.
Mol Psychiatry. 2024 Feb 19. doi: 10.1038/s41380-024-02458. PubMed
SONG J, Jonsson L, Lu Y, Bergen SE, et al Key subphenotypes of bipolar disorder are differentially associated with
polygenic liabilities for bipolar disorder, schizophrenia, and major depressive
disorder.
Mol Psychiatry. 2024 Feb 14. doi: 10.1038/s41380-024-02448. PubMedAbstract available
BENRIMOH D, Dlugunovych V, Wright AC, Phalen P, et al Correction: On the proportion of patients who experience a prodrome prior to
psychosis onset: a systematic review and meta-analysis.
Mol Psychiatry. 2024 Feb 14. doi: 10.1038/s41380-024-02481. PubMed
KOTOV R, Carpenter WT, Cicero DC, Correll CU, et al Psychosis superspectrum II: neurobiology, treatment, and implications.
Mol Psychiatry. 2024 Feb 14. doi: 10.1038/s41380-024-02410. PubMedAbstract available
ZHU Y, Maikusa N, Radua J, Samann PG, et al Using brain structural neuroimaging measures to predict psychosis onset for
individuals at clinical high-risk.
Mol Psychiatry. 2024 Feb 9. doi: 10.1038/s41380-024-02426. PubMedAbstract available
GEORGIADIS F, Lariviere S, Glahn D, Hong LE, et al Connectome architecture shapes large-scale cortical alterations in schizophrenia:
a worldwide ENIGMA study.
Mol Psychiatry. 2024 Feb 9. doi: 10.1038/s41380-024-02442. PubMedAbstract available
BENRIMOH D, Dlugunovych V, Wright AC, Phalen P, et al On the proportion of patients who experience a prodrome prior to psychosis
onset: A systematic review and meta-analysis.
Mol Psychiatry. 2024 Feb 2. doi: 10.1038/s41380-024-02415. PubMedAbstract available
PODVIN S, Jones J, Kang A, Goodman R, et al Human iN neuronal model of schizophrenia displays dysregulation of chromogranin B
and related neuropeptide transmitter signatures.
Mol Psychiatry. 2024 Feb 2. doi: 10.1038/s41380-024-02422. PubMedAbstract available
SHAKESHAFT A, Martin J, Dennison CA, Riglin L, et al Estimating the impact of transmitted and non-transmitted psychiatric and
neurodevelopmental polygenic scores on youth emotional problems.
Mol Psychiatry. 2024;29:238-246. PubMedAbstract available
January 2024
CHUNG Y, Dienel SJ, Belch MJ, Fish KN, et al Altered Rbfox1-Vamp1 pathway and prefrontal cortical dysfunction in
schizophrenia.
Mol Psychiatry. 2024 Jan 25. doi: 10.1038/s41380-024-02417. PubMedAbstract available
CHEN H, Lei Y, Li R, Xia X, et al Resting-state EEG dynamic functional connectivity distinguishes non-psychotic
major depression, psychotic major depression and schizophrenia.
Mol Psychiatry. 2024 Jan 24. doi: 10.1038/s41380-023-02395. PubMedAbstract available
DAVIES C, Martins D, Dipasquale O, McCutcheon RA, et al Connectome dysfunction in patients at clinical high risk for psychosis and
modulation by oxytocin.
Mol Psychiatry. 2024 Jan 19. doi: 10.1038/s41380-024-02406. PubMedAbstract available
WOLFF A, Northoff G Temporal imprecision of phase coherence in schizophrenia and psychosis-dynamic
mechanisms and diagnostic marker.
Mol Psychiatry. 2024 Jan 16. doi: 10.1038/s41380-023-02337. PubMedAbstract available
JONAS KG, Cannon TD, Docherty AR, Dwyer D, et al Psychosis superspectrum I: Nosology, etiology, and lifespan development.
Mol Psychiatry. 2024 Jan 10. doi: 10.1038/s41380-023-02388. PubMedAbstract available
SI S, Bi A, Yu Z, See C, et al Mapping gray and white matter volume abnormalities in early-onset psychosis: an
ENIGMA multicenter voxel-based morphometry study.
Mol Psychiatry. 2024 Jan 10. doi: 10.1038/s41380-023-02343. PubMedAbstract available
RUBIO JM, Lencz T, Cao H, Kraguljac N, et al Replication of a neuroimaging biomarker for striatal dysfunction in psychosis.
Mol Psychiatry. 2024 Jan 4. doi: 10.1038/s41380-023-02381. PubMedAbstract available
December 2023
DONG P, Voloudakis G, Fullard JF, Hoffman GE, et al Convergence of the dysregulated regulome in schizophrenia with polygenic risk and
evolutionarily constrained enhancers.
Mol Psychiatry. 2023 Dec 25. doi: 10.1038/s41380-023-02370. PubMedAbstract available
KENDLER KS, Ohlsson H, Sundquist J, Sundquist K, et al The relationship between familial-genetic risk and pharmacological treatment in a
Swedish national sample of patients with major depression, bipolar disorder, and
schizophrenia.
Mol Psychiatry. 2023 Dec 20. doi: 10.1038/s41380-023-02365. PubMedAbstract available
KOMATSU H, Onoguchi G, Silverstein SM, Jerotic S, et al Retina as a potential biomarker in schizophrenia spectrum disorders: a systematic
review and meta-analysis of optical coherence tomography and electroretinography.
Mol Psychiatry. 2023 Dec 11. doi: 10.1038/s41380-023-02340. PubMedAbstract available
OKADA N, Fukunaga M, Miura K, Nemoto K, et al Subcortical volumetric alterations in four major psychiatric disorders: a
mega-analysis study of 5604 subjects and a volumetric data-driven approach for
classification.
Mol Psychiatry. 2023;28:5206-5216. PubMedAbstract available
GRIECO SF, Johnston KG, Gao P, Garduno BM, et al Anatomical and molecular characterization of parvalbumin-cholecystokinin
co-expressing inhibitory interneurons: implications for neuropsychiatric
conditions.
Mol Psychiatry. 2023;28:5293-5308. PubMedAbstract available
WEI W, Deng L, Qiao C, Yin Y, et al Neural variability in three major psychiatric disorders.
Mol Psychiatry. 2023;28:5217-5227. PubMedAbstract available
KENDLER KS, Ohlsson H, Sundquist J, Sundquist K, et al Selecting cases of major psychiatric and substance use disorders in Swedish
national registries on the basis of clinical features to maximize the strength or
specificity of the genetic risk.
Mol Psychiatry. 2023;28:5195-5205. PubMedAbstract available
ZHENG H, Webster MJ, Weickert CS, Beasley CL, et al Cytomegalovirus antibodies are associated with mood disorders, suicide, markers
of neuroinflammation, and microglia activation in postmortem brain samples.
Mol Psychiatry. 2023;28:5282-5292. PubMedAbstract available
November 2023
NORTHOFF G, Daub J, Hirjak D Overcoming the translational crisis of contemporary psychiatry - converging
phenomenological and spatiotemporal psychopathology.
Mol Psychiatry. 2023;28:4492-4499. PubMedAbstract available
October 2023
OWEN MJ, Legge SE, Rees E, Walters JTR, et al Genomic findings in schizophrenia and their implications.
Mol Psychiatry. 2023 Oct 18. doi: 10.1038/s41380-023-02293. PubMedAbstract available
LESH TA, Iosif AM, Tanase C, Vlasova RM, et al Extracellular free water elevations are associated with brain volume and maternal
cytokine response in a longitudinal nonhuman primate maternal immune activation
model.
Mol Psychiatry. 2023;28:4185-4194. PubMedAbstract available
ARNATKEVICIUTE A, Lemire M, Morrison C, Mooney M, et al Trans-ancestry meta-analysis of genome wide association studies of inhibitory
control.
Mol Psychiatry. 2023;28:4175-4184. PubMedAbstract available
RAVEN EP, Veraart J, Kievit RA, Genc S, et al In vivo evidence of microstructural hypo-connectivity of brain white matter in
22q11.2 deletion syndrome.
Mol Psychiatry. 2023;28:4342-4352. PubMedAbstract available
September 2023
ODKHUU S, Kim WS, Tsogt U, Shen J, et al Network biomarkers in recovered psychosis patients who discontinued
antipsychotics.
Mol Psychiatry. 2023 Sep 29. doi: 10.1038/s41380-023-02279. PubMedAbstract available
HARRISON PJ, Bannerman DM GRIN2A (NR2A): a gene contributing to glutamatergic involvement in schizophrenia.
Mol Psychiatry. 2023 Sep 22. doi: 10.1038/s41380-023-02265. PubMedAbstract available
ZHOU J, Xia Y, Li M, Chen Y, et al A higher dysregulation burden of brain DNA methylation in female patients
implicated in the sex bias of Schizophrenia.
Mol Psychiatry. 2023 Sep 11. doi: 10.1038/s41380-023-02243. PubMedAbstract available
FLYNN LT, Gao WJ DNA methylation and the opposing NMDAR dysfunction in schizophrenia and major
depression disorders: a converging model for the therapeutic effects of
psychedelic compounds in the treatment of psychiatric illness.
Mol Psychiatry. 2023 Sep 7. doi: 10.1038/s41380-023-02235. PubMedAbstract available
SOLMI M, Cortese S, Vita G, De Prisco M, et al An umbrella review of candidate predictors of response, remission, recovery, and
relapse across mental disorders.
Mol Psychiatry. 2023;28:3671-3687. PubMedAbstract available
MERRITT K, Luque Laguna P, Sethi A, Drakesmith M, et al The impact of cumulative obstetric complications and childhood trauma on brain
volume in young people with psychotic experiences.
Mol Psychiatry. 2023;28:3688-3697. PubMedAbstract available
WOOTTON O, Shadrin AA, Mohn C, Susser E, et al Genome-wide association study in 404,302 individuals identifies 7 significant
loci for reaction time variability.
Mol Psychiatry. 2023;28:4011-4019. PubMedAbstract available
CAMPBELL PD, Lee I, Thyme S, Granato M, et al Mitochondrial proteins encoded by the 22q11.2 neurodevelopmental locus regulate
neural stem and progenitor cell proliferation.
Mol Psychiatry. 2023;28:3769-3781. PubMedAbstract available
August 2023
NURMI EL, Laughlin CP, de Wit H, Palmer AA, et al Polygenic contributions to performance on the Balloon Analogue Risk Task.
Mol Psychiatry. 2023;28:3524-3530. PubMedAbstract available
HETTEMA JM, van den Oord EJCG, Zhao M, Xie LY, et al Methylome-wide association study of anxiety disorders.
Mol Psychiatry. 2023;28:3484-3492. PubMedAbstract available
May 2023
LICINIO J, Wong ML Psychosis and autism spectrum disorder: a special issue of Molecular Psychiatry.
Mol Psychiatry. 2023;28:1830-1832. PubMed